GeminIQ Website Logo

Viewing ADMA free

Subscribe for full history, 50+ metrics, screener, watchlist...

ADMA BIOLOGICS, INC.

ADMA

Companies in Biological Products, (No Diagnostic Substances)

ADMA BIOLOGICS, INC. (ADMA) — SEC Financial Statements & Analysis

ADMA BIOLOGICS, INC. (ADMA) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
13888619072103878845517463
Accounts Receivable Net Current
1361581381109950503050273137
Inventory Net
222206197191172170172180178173163162
Prepaid Expense And Other Assets Current
15778981064555
Assets Held For Sale Not Part Of Disposal Group Cu…
07---0------
Assets Current
511467403400352331318304276257274266
Property Plant And Equipment Net
656570585855545455545556
Intangible Assets Net Excluding Goodwill
110100000001
Goodwill
444444444444
Deferred Income Tax Assets Net
707374798184---0--
Operating Lease Right Of Use Asset
679989999101010
Assets
665624569558511489391376351329349343
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
212324302120161417161112
Accrued Liabilities And Other Liabilities
494029443234282834333029
Contract With Customer Liability Current
---000011000
Long Term Debt Current
332--0------
Operating Lease Liability Current
111111111111
Liabilities Of Disposal Group Including Discontinu…
03---0------
Liabilities Current
747056755356454453504242
Senior Long Term Notes
---737372101131131131142140
Long Term Debt Noncurrent
1946970--72------
Deferred Revenue Noncurrent
111122222222
Operating Lease Liability Noncurrent
679989999101010
Other Liabilities Noncurrent
-00000000000
Liabilities
275147138160137140159188197194198196
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Treasury Stock Value
-143-32-23-15-0-0----
Additional Paid In Capital
650671665661655658652645642641640638
Retained Earnings Accumulated Deficit
-116-162-211-247-282-309-420-456-488-506-489-491
Stockholders Equity
390477431398373349232188154135151147
Liabilities And Stockholders Equity
665624569558511489391376351329349343
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Outstanding
000000000000
Preferred Stock Shares Issued
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
300300300300300300300300300300300300
Shares Outstanding
232238238239239237236233232226226225
Common Stock Shares Issued
241240240239239237236233232226226225
Treasury Stock Common Shares
9211-0-0----

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-20.83%-13.19%----------
2025-15.97%-23.08%-23.72%-6.90%-15.80%-18.12%24.79%25.44%8.85%-8.67%-29.78%-47.26%
202437.81%61.33%89.90%42.00%59.02%29.70%1.98%-11.51%-18.46%3.69%6.79%10.16%
202313.45%3.36%12.89%-4.19%-11.82%-18.47%5.25%24.86%40.61%16.91%16.54%71.19%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
6.95
6.71
7.13
5.33
6.58
5.97
7.09
6.87
5.21
5.16
6.54
6.35
Quick Ratio
3.73
3.63
3.52
2.67
3.20
2.76
3.05
2.68
1.79
1.58
2.52
2.37
Working Capital
437.63M
396.97M
346.17M
324.62M
298.32M
275.87M
273.30M
259.51M
223.33M
207.21M
231.86M
224.29M
Leverage & Debt
Debt to Equity
0.70
0.31
0.32
0.40
0.37
0.40
0.68
1.00
1.28
1.43
1.30
1.34
Interest Coverage TTM
29.69
26.93
19.97
15.28
12.53
9.98
6.65
4.16
1.95
0.86
0.05
-0.70
Debt Ratio
0.41
0.24
0.24
0.29
0.27
0.29
0.41
0.50
0.56
0.59
0.57
0.57
Efficiency & Turnover
Asset Turnover TTM
0.87
0.92
1.02
1.01
1.07
1.04
1.04
0.92
0.82
0.76
0.72
0.65
Days Sales Outstanding TTM
84.21
74.56
70.16
53.82
59.21
33.13
38.83
36.94
49.07
30.34
40.68
48.77
Receivables Turnover TTM
4.33
4.90
5.20
6.78
6.16
11.02
9.40
9.88
7.44
12.03
8.97
7.48
Per Share Metrics
Diluted EPS TTM
0.69
0.60
0.86
0.84
0.85
0.81
0.28
0.14
-0.02
-0.13
-0.10
-0.18
Free Cash Flow Per Share TTM
0.46
0.12
0.17
0.27
0.38
0.47
0.34
0.29
0.07
0.02
-0.10
-0.23
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
61.27%
57.39%
54.71%
53.00%
52.58%
51.48%
48.93%
46.12%
39.39%
34.44%
30.74%
27.41%
Operating Profit Margin TTM
42.14%
37.53%
34.19%
32.82%
33.10%
32.59%
30.01%
25.42%
15.63%
8.38%
0.57%
-8.01%
Net Profit Margin TTM
32.43%
28.80%
42.87%
44.06%
45.01%
46.35%
17.80%
10.53%
-1.29%
-10.94%
-9.74%
-19.36%
Growth Metrics
Net Revenue Growth (1Y)
10.99%
19.63%
27.63%
43.58%
62.22%
65.15%
63.39%
58.69%
55.68%
67.59%
79.56%
89.07%
Net Income Growth (1Y)
-20.03%
-25.67%
207.41%
500.56%
-5,774.29%
-800.00%
-398.48%
-186.34%
-92.36%
-57.15%
-67.54%
-44.91%
EPS Growth (1Y)
-19.45%
-27.30%
202.21%
477.99%
-5,561.88%
-772.65%
-386.65%
-182.73%
-92.59%
-62.14%
-71.70%
-51.42%
Valuation Metrics
P/E TTM
12.86
29.58
16.70
21.05
22.81
20.22
68.82
74.69
-414.54
-35.85
-35.33
-20.39
P/B
5.45
9.11
8.11
11.04
12.63
11.45
20.22
13.80
9.83
7.49
5.33
5.60
P/S TTM
4.17
8.52
7.16
9.27
10.27
9.37
12.25
7.87
5.33
3.92
3.44
3.95
Market Cap
2.13B
4.35B
3.50B
4.40B
4.72B
4.00B
4.69B
2.60B
1.51B
1.01B
806.49M
821.70M
Enterprise Value
2.19B
4.33B
3.51B
4.31B
4.65B
3.97B
4.60B
2.51B
1.47B
961.03M
732.33M
759.19M
Calculated Values
Free Cash Flow TTM
107.90M
27.82M
40.73M
65.77M
90.64M
110.45M
79.39M
66.64M
16.13M
4.03M
-23.50M
-51.39M
Net Debt
58.71M
-15.49M
11.04M
-90.29M
-71.63M
-30.81M
-86.71M
-88.24M
-45.33M
-51.35M
-74.16M
-62.51M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-27Purchase
Owner: Grossman, Jerrold B
Title: -
Shares: 6,400
Price/Share: $7.91
Value: $50,624.00
Shares Owned: 520,284
Relationship: Director
Ownership: Direct
2026-05-12Purchase
Owner: Grossman, Jerrold B
Title: -
Shares: 12,500
Price/Share: $8.01
Value: $100,125.00
Shares Owned: 513,884
Relationship: Director
Ownership: Direct
2026-05-11Purchase
Owner: Grossman, Jerrold B
Title: -
Shares: 12,500
Price/Share: $8.01
Value: $100,125.00
Shares Owned: 501,384
Relationship: Director
Ownership: Direct
2026-03-16Sale
Owner: Grossman, Adam S
Title: President and CEO
Shares: 21,000
Price/Share: $15.16
Value: $318,360.00
Shares Owned: 2,112,777
Relationship: Director,Officer
Ownership: Direct
2026-03-09Sale
Owner: Kestenberg-Messina, Kaitl…
Title: COO and SVP, Compliance
Shares: 10,096
Price/Share: $15.63
Value: $157,800.48
Shares Owned: 466,600
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
86.23%
Inst. Shares: 203,553,999
Shares Outstanding: 236,072,751
2025-12-31
88.93%
Inst. Shares: 211,916,408
Shares Outstanding: 238,299,024
2025-09-30
88.06%
Inst. Shares: 210,120,665
Shares Outstanding: 238,602,978
2025-06-30
82.02%
Inst. Shares: 198,066,135
Shares Outstanding: 241,490,715
2025-03-31
82.27%
Inst. Shares: 195,606,585
Shares Outstanding: 237,775,476

Research Faster.
Invest Smarter.

ADMA BIOLOGICS, INC. (ADMA) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.